Current Medicine Around the World
2021 - December
The Effectiveness of Billroth-II with Braun Anastomosis in Laparoscopic Distal Gastrectomy for Gastric Cancer
Ngoc Hung Dang, Nhu Thanh Dang, Trong Thai Le, Van Linh Ho
Current Medicine Around the World, 2021 - December
Article DOI: 10.21614/sgo-eC-383
Background: Gastric cancer is a common disease in the world, among the leading digestive cancers. Until now, surgery, especially laparoscopic surgery, is the primary radical treatment. In there, reestablishment of the gastrointestinal continuity remains controversial. This study aims to evaluate the term postoperative complication and short-term outcomes after distal gastrectomy with Billroth II (Poly A) - Braun anastomosis for gastric cancer.

Methods: A prospective study on 42 patients who underwent laparoscopic distal gastrectomy with Billroth II â?" Braun anastomosis from October 2019 to June 2020. Postoperative complication and short-term outcomes were evaluated.

Results: The post-gastrectomy syndrome with persistent diarrhea accounted for 9.52%; alkaline gastritis accounted for 4.76%. Patients with Grade 2 according to Clavien - Dindo classification accounted for 14.28%. Most patients were with good surgical results of VISICK I (71.44%). 14.28% was with quite good results (VISICK II) and moderate results accounted for 14.28% (VISICK III). There was no case of persistent medical treatment or reoperation.

Conclusion: Billroth II - Braun anastomosis is a good choice in laparoscopic distal gastrectomy for cancer with low rate of complications and mild postoperative symptoms that could be easily controlled with short-term medical treatment.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1965


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.